Ardelyx (ARDX) News
NASDAQ: ARDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.28+0.01 (+0.31%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ARDX news summary
We found 4 recent headlines mentioning Ardelyx (ARDX): 4 in the past week and 4 in the past 30 days, most often from PR Newswire, Nasdaq. For price context, ARDX is up 0.31% at $3.28. The most recent story, "New Strong Sell Stocks for October 9th", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Ardelyx headlines
- New Strong Sell Stocks for October 9thACH, ARDX and DPRO have been added to the Zacks Rank #5 (Strong Sell) List on October 9th, 2026.NasdaqACH, ARDX, DPRO
- ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS LawLOS ANGELES, Oct. 8, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ardelyx, Inc.…PR Newswire
- SueWallSt Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026 - ARDXArdelyx's chief executive, two successive chief financial officers, and its chief commercial officer are each named as individual defendants in a securities class action alleging they controlled…PR Newswire
- ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud LawsuitNEW YORK, Oct. 7, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August…PR Newswire